Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines https://www.medrxiv.org/content/10.1101/2022.12.02.22282931
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines https://www.medrxiv.org/content/10.1101/2022.12.02.22282931